MNGI-14. LOSS OF HISTONE H3K27me3 IDENTIFIES A SUBSET OF MENINGIOMAS WITH INCREASED RISK OF RECURRENCE
Leah Katz(Israel Ministry of Health), Felix Sahm(German Cancer Research Center), Chandranath Sen(NYU Langone Health), Patrick N. Harter(Ludwig-Maximilians-Universität München), David Zagzag(NYU Langone Health), Michael Weller(University Hospital of Zurich), John G. Golfinos(NYU Langone Health), Christel Herold‐Mende, Marian C. Neidert(University of St.Gallen), Andreas von Deimling(German Cancer Research Center), David Reuß(German Cancer Research Center), Matija Snuderl, Joshua S. Silverman(NYU Langone Health), Wolfgang Wick(German Cancer Research Center), Thomas Hielscher(Ontario Institute for Cancer Research), Hans‐Georg Wirsching(University of Zurich), Peter Wu, Benjamin Liechty, Rajeev Sen(University of Washington), Peter Baumgarten(University Hospital Augsburg)
Cited by 1
Related Papers
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
|Nature Reviews Clinical Oncology|2020|1.9k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Glioblastoma in adults: a Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions
|Neuro-Oncology|2020|1.1k